mRNA vaccine development for cholangiocarcinoma: a precise pipeline
Abstract Cholangiocarcinoma (CHOL) is one of the most aggressive tumors worldwide and cannot be effectively treated by conventional and novel treatments, including immune checkpoint blockade therapy. The mRNA vaccine-based immunotherapeutic strategy has attracted much attention for various diseases,...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-07-01
|
Series: | Military Medical Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40779-022-00399-8 |